These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7627246)

  • 1. Caffeine pharmacokinetics in obesity and following significant weight reduction.
    Caraco Y; Zylber-Katz E; Berry EM; Levy M
    Int J Obes Relat Metab Disord; 1995 Apr; 19(4):234-9. PubMed ID: 7627246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine pharmacokinetics in obese and lean subjects.
    Caraco Y; Zylber-Katz E; Berry EM; Levy M
    Ann Pharmacother; 1995 Sep; 29(9):843-7. PubMed ID: 8547729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism.
    Caraco Y; Zylber-Katz E; Berry EM; Levy M
    Eur J Clin Pharmacol; 1995; 47(6):525-30. PubMed ID: 7768256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant weight reduction in obese subjects enhances carbamazepine elimination.
    Caraco Y; Zylber-Katz E; Berry EM; Levy M
    Clin Pharmacol Ther; 1992 May; 51(5):501-6. PubMed ID: 1587063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between basal metabolic rate, thermogenic response to caffeine, and body weight loss following combined low calorie and exercise treatment in obese women.
    Yoshida T; Sakane N; Umekawa T; Kondo M
    Int J Obes Relat Metab Disord; 1994 May; 18(5):345-50. PubMed ID: 8061728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of dexfenfluramine in obese and non-obese subjects.
    Cheymol G; Weissenburger J; Poirier JM; Gellee C
    Br J Clin Pharmacol; 1995 Jun; 39(6):684-7. PubMed ID: 7654489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation.
    Burstein R; Epstein Y; Charuzi I; Suessholz A; Karnieli E; Shapiro Y
    Int J Obes Relat Metab Disord; 1995 Aug; 19(8):558-61. PubMed ID: 7489026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine disposition in obesity.
    Abernethy DR; Todd EL; Schwartz JB
    Br J Clin Pharmacol; 1985 Jul; 20(1):61-6. PubMed ID: 4027137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of green tea on weight maintenance after body-weight loss.
    Kovacs EM; Lejeune MP; Nijs I; Westerterp-Plantenga MS
    Br J Nutr; 2004 Mar; 91(3):431-7. PubMed ID: 15005829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
    Ghobadi C; Johnson TN; Aarabi M; Almond LM; Allabi AC; Rowland-Yeo K; Jamei M; Rostami-Hodjegan A
    Clin Pharmacokinet; 2011 Dec; 50(12):809-22. PubMed ID: 22087867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Almonds vs complex carbohydrates in a weight reduction program.
    Wien MA; Sabaté JM; Iklé DN; Cole SE; Kandeel FR
    Int J Obes Relat Metab Disord; 2003 Nov; 27(11):1365-72. PubMed ID: 14574348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body composition and muscle constituents during weight loss: studies in obese patients following gastroplasty.
    Wadström C; Backman L; Forsberg AM; Nilsson E; Hultman E; Reizenstein P; Ekman M
    Obes Surg; 2000 Jun; 10(3):203-13. PubMed ID: 10932257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of the effect of antipyrine on caffeine kinetics in six healthy volunteer subjects.
    Soto J; Alsar MJ
    J Clin Pharm Ther; 1997 Jun; 22(3):191-5. PubMed ID: 9447474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjects.
    Castelli MC; Wong DF; Friedman K; Riley MG
    Clin Ther; 2011 Jul; 33(7):934-45. PubMed ID: 21722960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of obesity and major weight reduction on gastric emptying.
    Verdich C; Madsen JL; Toubro S; Buemann B; Holst JJ; Astrup A
    Int J Obes Relat Metab Disord; 2000 Jul; 24(7):899-905. PubMed ID: 10918538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
    Breum L; Pedersen JK; Ahlstrøm F; Frimodt-Møller J
    Int J Obes Relat Metab Disord; 1994 Feb; 18(2):99-103. PubMed ID: 8148931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity is associated with an altered autonomic nervous system response to nutrient restriction.
    Wijngaarden MA; Pijl H; van Dijk KW; Klaassen ES; Burggraaf J
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):648-51. PubMed ID: 23252937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in lean body mass in obese children during a weight reduction program: effect on short term and long term outcome.
    Schwingshandl J; Borkenstein M
    Int J Obes Relat Metab Disord; 1995 Oct; 19(10):752-5. PubMed ID: 8589770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Less fat reduction per unit weight loss in type 2 diabetic compared with nondiabetic obese individuals completing a very-low-calorie diet program.
    Baker ST; Jerums G; Prendergast LA; Panagiotopoulos S; Strauss BJ; Proietto J
    Metabolism; 2012 Jun; 61(6):873-82. PubMed ID: 22146094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin levels are associated with fat oxidation and dietary-induced weight loss in obesity.
    Verdich C; Toubro S; Buemann B; Holst JJ; Bülow J; Simonsen L; Søndergaard SB; Christensen NJ; Astrup A
    Obes Res; 2001 Aug; 9(8):452-61. PubMed ID: 11500525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.